167 filings
Page 6 of 9
8-K
0ie6rviss8
18 Sep 15
Other Events
12:00am
8-K
avxf86k3 w3zff86we6
19 Aug 15
FDA Grants Fast Track Designation to Cempra for Solithromycin in the Treatment of Community Acquired Bacterial Pneumonia
12:00am
8-K
jgtwxczczi59s
29 Jul 15
Cempra Reports Second Quarter 2015 Financial Results and Provides Corporate Update
12:00am
8-K
e22p0jt 2ye5
16 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
j8cub9ulj
7 Jul 15
Cempra Completes Patient Enrollment of Solitaire-IV Phase 3
12:00am
8-K
odbcr8g0c31n5etgf8a
22 May 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
cissgzf
30 Apr 15
Cempra Reports First Quarter 2015 Financial Results and Provides Corporate Update
12:00am
8-K
rce434rundb wp
24 Apr 15
Other Events
12:00am
8-K
j7746puejw2axmtqptl
25 Feb 15
Cempra Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
12:00am
8-K
pzn7 5itql3e7
13 Jan 15
Cempra Announces Full Exercise of Additional Share Option and Completion
12:00am
8-K
3xroqdkd
8 Jan 15
Cempra Prices Public Offering of Common Stock
12:00am
8-K
1ic a0are
5 Jan 15
Cempra Announces Proposed Public Offering of $100 Million of Common Stock
12:00am
8-K
86hvks9iw4kj9w6r85
5 Jan 15
Cempra Announces Positive Topline Phase 3 Clinical Results for Oral Solithromycin in the Treatment of Community Acquired Bacterial Pneumonia
12:00am
8-K
97ps13 xiww
19 Nov 14
Cempra to Receive BARDA Funding for 1b and Start-up of Phase 2/3 Solithromycin Pediatric Studies
12:00am
8-K
qymcxme1tp6e
29 Oct 14
Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update
12:00am
8-K
jv2 5rc4uji0v9eqi
17 Oct 14
Entry into a Material Definitive Agreement
12:00am
8-K
ygqaf614xwcl5szf6cf
25 Sep 14
Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial
12:00am
8-K
wuvyt xfmm5oi8h2
9 Sep 14
Cempra, Inc. Receives $10 million Milestone Payment from Toyama Chemical Co. Triggered by Solithromycin’s Clinical Development Progress in Japan
12:00am
8-K
9ba1tn
12 Aug 14
Other Events
12:00am
8-K
ajvk hjz64
7 Aug 14
This presentation contains forward-looking statements regarding future events. These statements
12:00am